Ortivus AB (publ) (ORTI-B.ST)
SEK 1.48
(-6.62%)
SEK 1.48
(-6.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -17.61 Million SEK | -380.45% |
| 2022 | 5.84 Million SEK | -37.44% |
| 2021 | 9.34 Million SEK | -17.96% |
| 2020 | 11.39 Million SEK | 175.66% |
| 2019 | -15.05 Million SEK | -16.33% |
| 2018 | -12.94 Million SEK | -23.88% |
| 2017 | -10.44 Million SEK | -104.38% |
| 2016 | -5.11 Million SEK | 7.68% |
| 2015 | -5.53 Million SEK | -431.95% |
| 2014 | 1.66 Million SEK | 111.83% |
| 2013 | -14.09 Million SEK | -807.63% |
| 2012 | 1.99 Million SEK | 105.22% |
| 2011 | -38.17 Million SEK | -17.13% |
| 2010 | -32.59 Million SEK | -85.0% |
| 2009 | -17.61 Million SEK | 57.91% |
| 2008 | -41.85 Million SEK | 22.36% |
| 2007 | -53.91 Million SEK | 58.01% |
| 2006 | -128.38 Million SEK | -487.99% |
| 2005 | -21.83 Million SEK | -245.06% |
| 2004 | 15.05 Million SEK | 3.18% |
| 2003 | 14.58 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.88 Million SEK | 1.36% |
| 2024 Q2 | -7.34 Million SEK | -315.63% |
| 2023 Q3 | -11.04 Million SEK | -136.32% |
| 2023 Q1 | 494 Thousand SEK | 63.04% |
| 2023 FY | -16.39 Million SEK | -380.45% |
| 2023 Q4 | -1.9 Million SEK | 82.73% |
| 2023 Q2 | -4.67 Million SEK | -1045.75% |
| 2022 Q1 | 1.93 Million SEK | 13.26% |
| 2022 Q2 | 3.49 Million SEK | 81.15% |
| 2022 Q3 | 65 Thousand SEK | -98.14% |
| 2022 Q4 | 303 Thousand SEK | 366.15% |
| 2022 FY | 5.84 Million SEK | -37.44% |
| 2021 Q3 | 2.73 Million SEK | -13.66% |
| 2021 Q2 | 3.17 Million SEK | 82.92% |
| 2021 FY | 9.34 Million SEK | -17.96% |
| 2021 Q1 | 1.73 Million SEK | -20.03% |
| 2021 Q4 | 1.7 Million SEK | -37.71% |
| 2020 Q3 | 1.22 Million SEK | -82.14% |
| 2020 Q1 | 1.11 Million SEK | 164.24% |
| 2020 Q2 | 6.88 Million SEK | 518.97% |
| 2020 FY | 11.39 Million SEK | 175.66% |
| 2020 Q4 | 2.16 Million SEK | 76.32% |
| 2019 Q4 | -1.73 Million SEK | 48.0% |
| 2019 FY | -15.05 Million SEK | -16.33% |
| 2019 Q3 | -3.32 Million SEK | 27.17% |
| 2019 Q2 | -4.57 Million SEK | 21.7% |
| 2019 Q1 | -5.83 Million SEK | -52.91% |
| 2018 FY | -12.94 Million SEK | -23.88% |
| 2018 Q1 | -3.64 Million SEK | -89.48% |
| 2018 Q2 | -4.53 Million SEK | -24.7% |
| 2018 Q3 | -944 Thousand SEK | 79.2% |
| 2018 Q4 | -3.81 Million SEK | -304.45% |
| 2017 Q4 | -1.92 Million SEK | 47.56% |
| 2017 Q3 | -3.66 Million SEK | -34.18% |
| 2017 Q2 | -2.73 Million SEK | -27.93% |
| 2017 Q1 | -2.13 Million SEK | -248.61% |
| 2017 FY | -10.44 Million SEK | -104.38% |
| 2016 Q1 | -4.49 Million SEK | -204.47% |
| 2016 FY | -5.11 Million SEK | 7.68% |
| 2016 Q4 | 1.43 Million SEK | 96.98% |
| 2016 Q3 | 729 Thousand SEK | 126.21% |
| 2016 Q2 | -2.78 Million SEK | 38.16% |
| 2015 Q2 | 132 Thousand SEK | -74.66% |
| 2015 Q3 | -4.71 Million SEK | -3670.45% |
| 2015 Q1 | 521 Thousand SEK | 114.1% |
| 2015 Q4 | -1.47 Million SEK | 68.66% |
| 2015 FY | -5.53 Million SEK | -431.95% |
| 2014 Q1 | 1.86 Million SEK | 126.93% |
| 2014 FY | 1.66 Million SEK | 111.83% |
| 2014 Q3 | 1.9 Million SEK | 19.8% |
| 2014 Q4 | -3.69 Million SEK | -293.81% |
| 2014 Q2 | 1.59 Million SEK | -14.74% |
| 2013 Q3 | -2.39 Million SEK | 19.14% |
| 2013 Q4 | -6.92 Million SEK | -189.27% |
| 2013 FY | -14.09 Million SEK | -807.63% |
| 2013 Q1 | -1.81 Million SEK | 0.98% |
| 2013 Q2 | -2.96 Million SEK | -63.47% |
| 2012 Q2 | 3.35 Million SEK | 208.64% |
| 2012 FY | 1.99 Million SEK | 105.22% |
| 2012 Q1 | -3.08 Million SEK | 74.77% |
| 2012 Q3 | 3.55 Million SEK | 5.93% |
| 2012 Q4 | -1.83 Million SEK | -151.48% |
| 2011 Q2 | -11.94 Million SEK | -139.11% |
| 2011 Q3 | -8.99 Million SEK | 24.64% |
| 2011 Q4 | -12.24 Million SEK | -36.07% |
| 2011 FY | -38.17 Million SEK | -17.13% |
| 2011 Q1 | -4.99 Million SEK | -16.63% |
| 2010 Q2 | -9.63 Million SEK | -16.27% |
| 2010 Q3 | -10.39 Million SEK | -7.94% |
| 2010 FY | -32.59 Million SEK | -85.0% |
| 2010 Q4 | -4.28 Million SEK | 58.82% |
| 2010 Q1 | -8.28 Million SEK | 0.0% |
| 2009 FY | -17.61 Million SEK | 57.91% |
| 2008 FY | -41.85 Million SEK | 22.36% |
| 2007 FY | -53.91 Million SEK | 58.01% |
| 2006 FY | -128.38 Million SEK | -487.99% |
| 2005 FY | -21.83 Million SEK | -245.06% |
| 2004 FY | 15.05 Million SEK | 3.18% |
| 2003 FY | 14.58 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AddLife AB (publ) | 585 Million SEK | 103.011% |
| Biotage AB (publ) | 376 Million SEK | 104.684% |
| Bonesupport Holding AB (publ) | 13.93 Million SEK | 226.432% |
| Doxa AB (publ) | 269.4 Million SEK | 106.537% |
| Elekta AB (publ) | 2.03 Billion SEK | 100.864% |
| iZafe Group AB (publ) | -35.63 Million SEK | 50.577% |
| Ortivus AB (publ) | -17.61 Million SEK | -0.0% |
| Q-linea AB (publ) | -230.58 Million SEK | 92.362% |
| S2Medical AB (publ) | -15.26 Million SEK | -15.384% |
| Synsam AB (publ) | 696 Million SEK | 102.53% |